BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35332616)

  • 1. Values and preferences of the general population in Indonesia in relation to rapid COVID-19 antigen self-tests: A cross-sectional survey.
    Thomas C; Shilton S; Thomas C; Batheja D; Goel S; Mone Iye C; Ivanova E; Martínez-Pérez GZ
    Trop Med Int Health; 2022 May; 27(5):522-536. PubMed ID: 35332616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-testing for SARS-CoV-2 in São Paulo, Brazil: results of a population-based values and attitudes survey.
    Martínez-Pérez GZ; Shilton S; Saruê M; Cesario H; Banerji A; Batheja D; Cunha JP; Baptista R; Schirmer J; Ivanova Reipold E; Machado Dias A
    BMC Infect Dis; 2022 Sep; 22(1):720. PubMed ID: 36056299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 self-testing in Peru: a cross-sectional survey of values and attitudes of the general population.
    Martínez-Pérez GZ; Shilton S; Mallma Salazar PS; Pflucker Oses P; Torres-Slimming PA; Batheja D; Banerji A; Mallery A; Ivanova Reipold E; Carcamo C
    BMJ Open; 2023 Jul; 13(7):e068980. PubMed ID: 37407037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. People's willingness to use COVID-19 self-testing in Nigeria: a cross-sectional survey.
    Folayan M; Shilton S; Undelikwo V; Alaba O; Amusan R; Ibrahim M; Ogbozor PA; Mojisola O; Batheja D; Banerji A; Ivanova Reipold E; Martínez-Pérez GZ
    BMJ Open; 2023 Jan; 13(1):e063323. PubMed ID: 36717135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 self-testing in Nigeria: Stakeholders' opinions and perspectives on its value for case detection.
    Undelikwo VA; Shilton S; Folayan MO; Alaba O; Reipold EI; Martínez-Pérez GZ
    PLoS One; 2023; 18(4):e0282570. PubMed ID: 37053243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 self-testing, a way to "live side by side with the coronavirus": Results from a qualitative study in Indonesia.
    Thomas C; Shilton S; Thomas C; Iye CM; Martínez-Pérez GZ
    PLOS Glob Public Health; 2022; 2(10):e0000514. PubMed ID: 36962512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Kenyans Likely to Use COVID-19 Self-Testing Kits? Results From a Cross-Sectional Survey.
    Manguro G; Shilton S; Omenda S; Owira P; Batheja D; Banerji A; Chabeda SV; Temmerman M; Jako W; Ndungu J; Luchters S; Ivanova Reipold E; Martínez-Pérez GZ
    Int J Public Health; 2022; 67():1604918. PubMed ID: 36090834
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccine-hesitant individuals accumulate additional COVID-19 risk due to divergent perception and behaviors related to SARS-CoV-2 testing: a population-based, cross-sectional study.
    Wratil PR; Kotter K; Bischof ML; Hollerbach S; Apak E; Kalteis AL; Nayeli-Pflantz T; Kaderali L; Adorjan K; Keppler OT
    Infection; 2023 Aug; 51(4):909-919. PubMed ID: 36355269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Screening of SARS-CoV-2 With Rapid Antigen Tests in a Receding Omicron Wave: Population-Based Survey for Epidemiologic Evaluation.
    Kwan TH; Wong NS; Chan CP; Yeoh EK; Wong SY; Lee SS
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40175. PubMed ID: 36240027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of At-Home COVID-19 Tests - United States, August 23, 2021-March 12, 2022.
    Rader B; Gertz A; Iuliano AD; Gilmer M; Wronski L; Astley CM; Sewalk K; Varrelman TJ; Cohen J; Parikh R; Reese HE; Reed C; Brownstein JS
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(13):489-494. PubMed ID: 35358168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public knowledge of SARS-CoV-2 serological and viral lineage laboratory testing and result interpretation: A GENCOV study cross-sectional survey.
    Morgan G; Briollais L; Clausen M; Casalino S; Mighton C; Chowdhary S; Frangione E; Fung CYJ; Arnoldo S; Bearss E; Binnie A; Borgundvaag B; Dagher M; Devine L; Friedman SM; Khan Z; McGeer A; McLeod SL; Richardson D; Stern S; Taher A; Wong I; Zarei N; Bombard Y; Lerner-Ellis J; Taher J
    Clin Biochem; 2023 Aug; 118():110607. PubMed ID: 37406717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement with daily testing instead of self-isolating in contacts of confirmed cases of SARS-CoV-2.
    Martin AF; Denford S; Love N; Ready D; Oliver I; Amlôt R; Rubin GJ; Yardley L
    BMC Public Health; 2021 Jun; 21(1):1067. PubMed ID: 34090404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the omicron period: a cross-sectional study.
    Venekamp RP; Schuit E; Hooft L; Veldhuijzen IK; van den Bijllaardt W; Pas SD; Zwart VF; Lodder EB; Hellwich M; Koppelman M; Molenkamp R; Wijers CJH; Vroom IH; Smeets LC; Nagel-Imming CRS; Han WGH; van den Hof S; Kluytmans JAJW; van de Wijgert JHHM; Moons KGM
    Clin Microbiol Infect; 2023 Mar; 29(3):391.e1-391.e7. PubMed ID: 36379401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The validity of self-reported SARS-CoV-2 results among postpartum respondents.
    McCarthy K; Maru S; Nowlin S; Ram P; Glazer KB; Janevic T
    Paediatr Perinat Epidemiol; 2022 Jul; 36(4):518-524. PubMed ID: 35257392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for SARS-CoV-2 rapid antigen tests during the COVID-19 pandemic: evidence from the general adult population.
    Hajek A; König HH
    Public Health; 2022 Jun; 207():19-23. PubMed ID: 35483163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients.
    Torres I; Poujois S; Albert E; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Apr; 27(4):636.e1-636.e4. PubMed ID: 33421573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of and Attitudes toward Tests for the Detection of SARS-CoV-2 and Corresponding Antibodies: Results of a Nationally Representative Survey in Late Summer 2021].
    Hajek A; Nedjad M; Kretzler B; König HH
    Gesundheitswesen; 2023 Jan; 85(1):26-35. PubMed ID: 36084943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness to Use Home Collection Methods to Provide Specimens for SARS-CoV-2/COVID-19 Research: Survey Study.
    Hall EW; Luisi N; Zlotorzynska M; Wilde G; Sullivan P; Sanchez T; Bradley H; Siegler AJ
    J Med Internet Res; 2020 Sep; 22(9):e19471. PubMed ID: 32790639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Values of COVID-19 Self-Testing among Urban and Rural South Africans: A Cross-Sectional Survey.
    Brumwell AN; Babatunde GB; Wilson MW; le Roux K; Marks MM; Adam JK; Ivanova E; Batheja D; Goel S; Shilton S; Martínez-Pérez GZ
    Prev Med Rep; 2023 Apr; 32():102114. PubMed ID: 36686721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.